ARTICLE SYNOPSIS...Pharmaceutical companies have been worth looking at since the Affordable Health Care Act was introduced.
ARTICLE SYNOPSIS...After forming a large base over the last two and a half years, Eli Lilly & Co. surged to resistance on expanding volume. A breakout would be long-term bullish.
ARTICLE SYNOPSIS...The National Institute for Health (NIH) and the Foundation for the NIH (FNIH) announced on April 17, 2020 via a news release that they are bringing together sixteen of the leading biopharmaceutical companies in conjunction with other national and interna
ARTICLE SYNOPSIS...Eli Lilly & Co.(LLY) is a large cap pharmaceutical company in the health care sector. As well as the maker of many popular drugs, LLY is also the maker of Zepbound, the popular weight loss drug. Let's take a look at its price charts.
ARTICLE SYNOPSIS...Eli Lilly has moved aggressively lower since making a yearly high in May, but it has bounced sharply in recent days as it attempts to alleviate a historically oversold position.
ARTICLE SYNOPSIS...The health-care sector has been strong lately, and Eli Lilly is doing its part with a consolidation breakout on good volume.
ARTICLE SYNOPSIS...Moving averages Part 2 Ehlers Leading Indicator (ELI) by John Ehlers Most technical indicators use a moving average of some kind, and this usually dooms the indicator to lag price. Some indicators use momentum, or rate of change, to generate a leading f